You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys CMV IgM IVD Elecsys® CMV IgM CPS_000458 04784618160 CMV IgM Elecsys cobas e 100 Elecsys CMV IgM 04015630938926 Reagents, kits 100 tests cobas e 411/601/602 true 07027133190 CMV IgM Elecsys E2G 300 Elecsys CMV IgM 04015630940189 Reagents, kits 300 tests cobas e 402/801 true 04784618190 CMV IgM Elecsys cobas e 100 Elecsys CMV IgM 04015630923502 Reagents, kits 100 tests cobas e 411/601/602 true ms_04784618160_USA Elecsys CMV IgM en 2 FF000000026C340E FF00000000F51C0E 04784618160 618 cobas e 411 2325 cobas e 602 623 MODULAR ANALYTICS E-MODULE 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of IgM antibodies to CMV in human serum, lithium‑heparin plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended as an aid in the diagnosis of recent or current CMV infection in individuals for which a CMV IgM test was ordered, including pregnant women. Performance characteristics have not been evaluated in immunocompromised or immunosuppressed individuals. This test is not intended for use in neonatal screening or for use at point of care facilities. This test is not intended for use in screening blood and plasma donors.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027133500 Elecsys CMV IgM en 1 FF0000000197A60E FF0000000197A60E 07027133190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to cytomegalovirus in human serum and plasma.Results obtained with this assay are used as an aid in the diagnosis of recent CMV infections.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07027133501 Elecsys CMV IgM en 2 FF00000005C8720E FF00000001F61F0E 07027133190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of IgM antibodies to CMV in human serum, lithium‑heparin plasma, K2‑EDTA plasma, and K3‑EDTA plasma. The test is intended as an aid in the diagnosis of recent or current CMV infection in individuals for which a CMV IgM test was ordered, including pregnant women. Performance characteristics have not been evaluated in immunocompromised or immunosuppressed individuals. This test is not intended for use in neonatal screening or for use at point of care facilities. This test is not intended for use in screening blood and plasma donors.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027133500 Elecsys CMV IgM en 2 FF000000047AD80E FF00000000E8980E 07027133190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to cytomegalovirus in human serum and plasma.Results obtained with this assay are used as an aid in the diagnosis of recent CMV infections.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 04784618500 Elecsys CMV IgM en 10 FF00000005218E0E FF000000000D040E 04784618190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of IgM antibodies to cytomegalovirus in human serum and plasma.Results obtained with this assay are used as an aid in the diagnosis of recent CMV infections.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en